Product spotlight

15
Jun

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals

Top advantages of ordering NativeSkin access® vs sourcing skin directly from hospitals Interested in trying NativeSkin access®? Do you still think that sourcing skin samples directly from hospitals is the only valid way? Let us change your mind with these top advantages to ordering  NativeSkin access® online! NativeSkin access® is a patented human skin model that makes the culture, treatment,
Read more
10
Jun

Injection site reactions platform

ISR PlatformA PROPRIETARY PLATFORM TO TEST INJECTION SITE REACTIONS IN HUMANS AHEAD OF CLINICAL TRIAL.A NEW PROPRIETARY RESEARCH TOOL TO IDENTIFY MAST CELLS-DEPENDENT & INDEPENDENT INJECTION SITE REACTIONS IN HUMAN SKIN. Today, biologics represent one of the fastest growing markets within the pharmaceutical industry. The pipeline of biological drugs is growing at a rapid pace with a global market expected
Read more
30
Nov

Human connective tissue mast cells

Human connective tissue mast cells A cellular model to better understand the underlying mechanisms of Injection Site Reactions (ISRs) and other severe allergic reactions. Mast cell culture assays are critical to better understand the kinetics and dynamics underlying inflammatory reactions. Genoskin’s team of experts has developed a method to grow connective tissue-type mast cells (CTMCs) derived from the peripheral blood
Read more
28
Oct

A unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin

The FlowSkin® platform : a unique ex vivo perfused human skin model to test pharmacokinetic and systemic administration in human skin When human tissue culture meets microfluidic technology, it leads to the first perfused human skin model ; an amazing platform to overcome the challenges of drug development and replace animal testing. Almost 10 years ago now, Genoskin developed the
Read more
4
Sep

Genoskin launches new offering: NativeSkin access

Genoskin launches new skin offering, NativeSkin® access, that increases accessibility to animal testing alternatives NativeSkin, the only ex vivo human skin model sold online, will be available to purchase daily at a key price point, making it easier to order even for larger volume sales Toulouse, France & Salem, MA, USA, September 1, 2020 - Genoskin, a biotechnology company developing ready-to-use human skin
Read more
25
Oct

Genoskin granted new patent on subcutaneous injection model

Genoskin granted a new patent on ex vivo subcutaneous injection model The French National Institute for Intellectual Property (INPI) granted Genoskin's latest patent on its unique ex vivo subcutaneous injection model, HypoSkin®. A boom in the subcutaneous biologics market Today, subcutaneous injection is one of the most common methods to deliver a drug into the human body. Its use has increased significantly
Read more